These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 2313489

  • 1. FDA regulations and guidelines.
    Rothschild A.
    J Parenter Sci Technol; 1990; 44(1):26-9. PubMed ID: 2313489
    [No Abstract] [Full Text] [Related]

  • 2. Foreign establishment registration and listing. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2001 Nov 27; 66(228):59138-61. PubMed ID: 11776289
    [Abstract] [Full Text] [Related]

  • 3. A strike against preemption.
    Nat Biotechnol; 2009 May 27; 27(5):397. PubMed ID: 19430422
    [Abstract] [Full Text] [Related]

  • 4. Reaction of FDA to a fundamental change in the nature of regulations.
    Kennedy D.
    J Parenter Drug Assoc; 1979 May 27; 33(1):17-20. PubMed ID: 253023
    [No Abstract] [Full Text] [Related]

  • 5. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR.
    Suffolk Univ Law Rev; 2003 May 27; 36(3):787-819. PubMed ID: 16493844
    [No Abstract] [Full Text] [Related]

  • 6. FDA user fees and innovation.
    Somberg J.
    Am J Ther; 2008 May 27; 15(2):97. PubMed ID: 18356626
    [No Abstract] [Full Text] [Related]

  • 7. ISO 9000. Policy implications for FDA. Taking the pulse of increasing global use of the ISO series of uniform quality standards by FDA regulated industries.
    Schwemer WL, Lynch MA.
    J Parenter Sci Technol; 1993 May 27; 47(3):101-18. PubMed ID: 8360802
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Supplements and other changes to an approved application. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2004 Apr 08; 69(68):18727-67. PubMed ID: 15072041
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. FDA's role in drug product recalls.
    Crawford SY.
    Am J Hosp Pharm; 1991 Dec 08; 48(12):2595-6. PubMed ID: 1814194
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prescription for the Orphan Drug Act: the impact of the FDA's 1992 regulations and the latest congressional proposals for reform.
    Clissold DB.
    Food Drug Law J; 1995 Dec 08; 50(1):125-47. PubMed ID: 10342989
    [No Abstract] [Full Text] [Related]

  • 17. Editorial: Some caveats for the FDA.
    Calif Med; 1973 Oct 08; 119(4):64-5. PubMed ID: 4749314
    [No Abstract] [Full Text] [Related]

  • 18. Off-label promotion.
    Somberg J.
    Am J Ther; 2006 Oct 08; 13(5):387. PubMed ID: 16988530
    [No Abstract] [Full Text] [Related]

  • 19. Dietary supplements: background for dialogue between the industry and the medical profession.
    Friede AI.
    Food Drug Law J; 1998 Oct 08; 53(3):413-20. PubMed ID: 10346719
    [No Abstract] [Full Text] [Related]

  • 20. Pediatric Research Equity Act.
    J Natl Cancer Inst; 2004 Dec 15; 96(24):1810. PubMed ID: 15601636
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.